These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9389424)

  • 21. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
    Pihlajamäki J; Rissanen J; Heikkinen S; Karjalainen L; Laakso M
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1039-44. PubMed ID: 9194752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the hexokinase II gene in subjects with insulin resistance and NIDDM and detection of a Gln142-->His substitution.
    Vidal-Puig A; Printz RL; Stratton IM; Granner DK; Moller DE
    Diabetes; 1995 Mar; 44(3):340-6. PubMed ID: 7883122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.
    Hansen L; Hansen T; Vestergaard H; Bjørbaek C; Echwald SM; Clausen JO; Chen YH; Chen MX; Cohen PT; Pedersen O
    Hum Mol Genet; 1995 Aug; 4(8):1313-20. PubMed ID: 7581368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycogen synthase polymorphism, insulin resistance and hypertension.
    Gharavi AG; Phillips RA; Finegood DT; Lipkowitz MS
    Blood Press; 1996 Mar; 5(2):86-90. PubMed ID: 8860096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance.
    Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS
    Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus in Chinese population.
    Wang C; Bai Y; Ouyang A
    Chin Med J (Engl); 1998 Oct; 111(10):903-5. PubMed ID: 11189236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Microsatellite polymorphism of muscle glycogen synthase gene and non-insulin dependent diabetes mellitus].
    Nakayama T; Tanuma Y; Soma M; Kanmatsuse K; Owada M; Nakabayashi H; Esumi M
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):597-604. PubMed ID: 7796924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects.
    Kuroyama H; Sanke T; Ohagi S; Furuta M; Furuta H; Nanjo K
    Diabetologia; 1994 May; 37(5):536-9. PubMed ID: 8056194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients.
    Pulkkinen A; Kareinen A; Saarinen L; Heikkinen S; Lehto S; Laakso M
    Metabolism; 1999 Jul; 48(7):853-6. PubMed ID: 10421225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.
    Tao T; Tanizawa Y; Matsutani A; Matsubara A; Kaneko T; Kaku K
    Diabetologia; 1995 Aug; 38(8):942-7. PubMed ID: 7589880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM.
    Saarinen L; Pulkkinen A; Kareinen A; Heikkinen S; Lehto S; Laakso M
    Diabetes Care; 1998 May; 21(5):849-50. PubMed ID: 9589253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.
    Schalin-Jäntti C; Härkonen M; Groop LC
    Diabetes; 1992 May; 41(5):598-604. PubMed ID: 1568529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity.
    Echwald SM; Bjørbaek C; Hansen T; Clausen JO; Vestergaard H; Zierath JR; Printz RL; Granner DK; Pedersen O
    Diabetes; 1995 Mar; 44(3):347-53. PubMed ID: 7883123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity.
    Lehto M; Huang X; Davis EM; Le Beau MM; Laurila E; Eriksson KF; Bell GI; Groop L
    Diabetologia; 1995 Dec; 38(12):1466-74. PubMed ID: 8786021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stimulation-induced increase in skeletal muscle glycogen synthase content is impaired in carriers of the glycogen synthase XbaI gene polymorphism.
    St-Onge J; Joanisse DR; Simoneau JA
    Diabetes; 2001 Jan; 50(1):195-8. PubMed ID: 11147787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [DNA polymorphism in the human glycogen synthase gene and non-insulin dependent diabetes mellitus in Japanese].
    Nakayama T; Nakabayashi H
    Nihon Rinsho; 1994 Oct; 52(10):2720-5. PubMed ID: 7983804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM.
    Shen GQ; Ikegami H; Kawaguchi Y; Fujisawa T; Hamada Y; Ueda H; Shintani M; Nojima K; Kawabata Y; Yamada K; Babaya N; Ogihara T
    Diabetes Care; 1998 Jul; 21(7):1086-9. PubMed ID: 9653600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects.
    Choi WH; O'Rahilly S; Buse JB; Rees A; Morgan R; Flier JS; Moller DE
    Diabetes; 1991 Dec; 40(12):1712-8. PubMed ID: 1756912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms.
    Ura S; Araki E; Kishikawa H; Shirotani T; Todaka M; Isami S; Shimoda S; Yoshimura R; Matsuda K; Motoyoshi S; Miyamura N; Kahn CR; Shichiri M
    Diabetologia; 1996 May; 39(5):600-8. PubMed ID: 8739921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.